Hls Therapeutics Stock Price on December 5, 2024
| HLS Stock | CAD 3.41 0.04 1.16% |
Below is the normalized historical share price chart for HLS Therapeutics extending back to March 28, 1980. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of HLS Therapeutics stands at 3.41, as last reported on the 11th of December 2024, with the highest price reaching 3.46 and the lowest price hitting 3.30 during the day.
If you're considering investing in HLS Stock, it is important to understand the factors that can impact its price. As of now, HLS Stock is relatively risky. HLS Therapeutics holds Efficiency (Sharpe) Ratio of 0.0256, which attests that the entity had a 0.0256% return per unit of volatility over the last 3 months. We have found twenty-nine technical indicators for HLS Therapeutics, which you can use to evaluate the volatility of the firm. Please check out HLS Therapeutics' risk adjusted performance of 0.0223, and Market Risk Adjusted Performance of 0.0403 to validate if the risk estimate we provide is consistent with the expected return of 0.0773%.
At this time, HLS Therapeutics' Other Stockholder Equity is very stable compared to the past year. As of the 11th of December 2024, Common Stock Total Equity is likely to grow to about 310.8 M, while Total Stockholder Equity is likely to drop about 64.7 M. . At this time, HLS Therapeutics' Price To Operating Cash Flows Ratio is very stable compared to the past year. As of the 11th of December 2024, Price To Free Cash Flows Ratio is likely to grow to 8.34, while Price To Sales Ratio is likely to drop 1.22. HLS Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 3.7227 | 50 Day MA 3.5598 | Beta 1.07 |
HLS |
Sharpe Ratio = 0.0256
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | HLS | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.02 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average HLS Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HLS Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.9641 | Enterprise Value Ebitda 7.6124 | Price Sales 1.9263 | Shares Float 19.3 M | Wall Street Target Price 6.0039 |
Related Headline
Profound Medical Headline on 5th of December 2024
Profound Medical Plans Public Share Offering - TipRanks by news.google.com
Profound Medical Plans Public Share Offering TipRanks
HLS Therapeutics Valuation on December 5, 2024
It is possible to determine the worth of HLS Therapeutics on a given historical date. On December 5, 2024 HLS was worth 3.38 at the beginning of the trading date compared to the closed value of 3.41. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of HLS Therapeutics stock. Still, in general, we apply an absolute valuation method to find HLS Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of HLS Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against HLS Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.53 | 3.55 | 3.37 | 3.51 | 86,800 | |
12/05/2024 | 3.38 | 3.51 | 3.24 | 3.41 | 77,300 |
| 3.41 | 3.49 | 3.20 | 3.40 | 72,800 |
| Backtest HLS Therapeutics | | | HLS Therapeutics History | | | HLS Therapeutics Valuation | Previous | Next |
HLS Therapeutics Trading Date Momentum on December 5, 2024
| On December 06 2024 HLS Therapeutics was traded for 3.40 at the closing time. The maximum traded price for the trading interval was 3.49 and the lowest daily price was 3.20 . The daily volume was recorded at 72.8 K. The volume of trading on 6th of December 2024 played a part in the next trading day price drop. The trading delta at closing time to the next closing price was 0.29% . The trading delta at closing time to the closing price today is 1.17% . |
HLS Therapeutics Fundamentals Correlations and Trends
By evaluating HLS Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among HLS Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. HLS financial account trend analysis is a perfect complement when working with valuation or volatility modules.About HLS Therapeutics Stock history
HLS Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for HLS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in HLS Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing HLS Therapeutics stock prices may prove useful in developing a viable investing in HLS Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 32.3 M | 23.1 M | |
| Net Loss | -21.2 M | -22.3 M |
HLS Therapeutics Quarterly Net Working Capital |
|
HLS Therapeutics Stock Technical Analysis
HLS Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
HLS Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
HLS Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on Toronto Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
HLS Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how HLS Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading HLS Therapeutics shares will generate the highest return on investment. By undertsting and applying HLS Therapeutics stock market strength indicators, traders can identify HLS Therapeutics entry and exit signals to maximize returns
HLS Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for HLS Therapeutics' price direction in advance. Along with the technical and fundamental analysis of HLS Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of HLS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0223 | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.42) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0303 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in HLS Stock
HLS Therapeutics financial ratios help investors to determine whether HLS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLS with respect to the benefits of owning HLS Therapeutics security.